Generic Ozempic will enter the Canadian market June 2026, and this shift will reshape access to semaglutide, (Ozempic generic name), for people managing type 2 diabetes and obesity. As patents for Novo’s Ozempic expire, demand continues to rise, and manufacturers prepare to release alternatives, Canadians will see major changes in its price and availability under …
Continue reading “New Generic Ozempic Launching Soon, Priced Under $100”
